Gut Onc Lab (@thegutonclab) 's Twitter Profile
Gut Onc Lab

@thegutonclab

A collaborative space led by GI medical oncologists to share research, learn together, and highlight what's evolving in GI cancers | #GIonc #OncTwitter

ID: 1930838906129481728

calendar_today06-06-2025 04:07:33

51 Tweet

57 Followers

9 Following

Gut Onc Lab (@thegutonclab) 's Twitter Profile Photo

We are growing!!! Love our biweekly lab meetings and all the cool ideas/collaborations. We are also trying to match Deepak Vadehra’s background game; guess we will get there one day. Watch this space for more 🚀 🔥 Tim Brown, MD MSCE Nicholas Hornstein Udhayvir Grewal Brandon Rose, MD, MPH Sawyer Bawek, DO

We are growing!!! Love our biweekly lab meetings and all the cool ideas/collaborations.
We are also trying to match <a href="/Deebacca/">Deepak Vadehra</a>’s background game; guess we will get there one day. 
Watch this space for more 🚀 🔥
<a href="/TimothyJBrownMD/">Tim Brown, MD MSCE</a> <a href="/GIMedOnc/">Nicholas Hornstein</a> <a href="/UGrewalMD/">Udhayvir Grewal</a> <a href="/BRoseMDMPH/">Brandon Rose, MD, MPH</a> <a href="/sawyer_bawek/">Sawyer Bawek, DO</a>
Gut Onc Lab (@thegutonclab) 's Twitter Profile Photo

Check out Dr Hornstein and team’s work demonstrating that the detection of subclonal fusions could serve as a potential marker of acquired resistance to anti-EGFR therapy in advanced CRC. Guardant Health MD Anderson Cancer Center

The Oncologist (@oncjournal) 's Twitter Profile Photo

Drs Udhayvir Grewal and Tim Brown, MD MSCE discuss the evolving treatment of #stmcsm with new targeted agents 🎯like zolbetuximab for #HER2- but #CLDN182+ disease. They describe 4 biomarker (MSI/MMR, HER2, PD-L1, CLDN18.2) profiles that guide therapy #GIonc doi.org/10.1093/oncolo…

Drs <a href="/UGrewalMD/">Udhayvir Grewal</a> and <a href="/TimothyJBrownMD/">Tim Brown, MD MSCE</a> discuss the evolving treatment of #stmcsm with new targeted agents 🎯like zolbetuximab for #HER2- but #CLDN182+ disease. They describe 4 biomarker (MSI/MMR, HER2, PD-L1, CLDN18.2) profiles that guide therapy #GIonc
doi.org/10.1093/oncolo…
Udhayvir Grewal (@ugrewalmd) 's Twitter Profile Photo

Checkout this piece where Tim Brown, MD MSCE and I try to take on the challenging task of describing zolbetuximab’s place in the advanced GEC treatment paradigm. Gut Onc Lab Nicholas Hornstein Deepak Vadehra P.S. we are already thinking about how we’re going to update this algorithm to

Checkout this piece where <a href="/TimothyJBrownMD/">Tim Brown, MD MSCE</a> and I try to take on the challenging task of describing zolbetuximab’s place in the advanced GEC treatment paradigm. <a href="/TheGutOncLab/">Gut Onc Lab</a> <a href="/GIMedOnc/">Nicholas Hornstein</a> <a href="/Deebacca/">Deepak Vadehra</a> 

P.S. we are already thinking about how we’re going to update this algorithm to
Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

As we’ve launched a new HAI program in Manhattan at Northwell, questions around optimal dosing strategies are front and center. This new City of Hope study asks: can we de-escalate initial FUDR dosing and still preserve outcomes in adjuvant HAI? Retrospective and single-center —

Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

CEA was discovered in 1965. By the 1970s, CEACAM5 was recognized as a hallmark of colorectal cancer. Yet in 2025, CRC still has no approved ADCs. That may change. 🚨 First-in-human data for Precem-TcT (anti-CEACAM5 + exatecan) now in Nature Medicine PROCEADE-CRC-01 dose

Udhayvir Grewal (@ugrewalmd) 's Twitter Profile Photo

Thank you Mayo Clinic Proceedings for the opportunity to record this special video highlighting my work as a UI Holden Comprehensive Cancer Center fellow focused on cholangiocarcinoma in patients with primary sclerosing cholangitis. Cholangiocarcinoma Foundation Gut Onc Lab YouTube link to video- youtu.be/czeDNtLSaXE?fe… Link to

deevyaparekh (@deevyaparekh) 's Twitter Profile Photo

An absolute honor to listen in on these incredible minds - mostly just absorbing information and nodding aggressively 😁

Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

Hot off the presses, probably my favorite interventional paper of 2025 (doesn't hurt that I look up to several of the authors as mentors or role models). 💉RAS vaccination is starting to look less like fantasy, more like reality. 🆕 Nature Medicine | Wainberg et al 🎯

Hot off the presses, probably my favorite interventional paper of 2025 (doesn't hurt that I look up to several of the authors as mentors or role models). 

💉RAS vaccination is starting to look less like fantasy, more like reality.

🆕 Nature Medicine | Wainberg et al
🎯
Gut Onc Lab (@thegutonclab) 's Twitter Profile Photo

Congratulations to our very own Deepak Vadehra for representing his institution Roswell Park on the National Comprehensive Cancer Network (NCCN) AYA Oncology Guideline. So proud to have you on the team. Congratulations to the panel and Dr Vadehra on this important and timely work! 👏 Tim Brown, MD MSCE Nicholas Hornstein Udhayvir Grewal

Congratulations to our very own <a href="/Deebacca/">Deepak Vadehra</a> for representing his institution <a href="/RoswellPark/">Roswell Park</a> on the <a href="/NCCN/">National Comprehensive Cancer Network (NCCN)</a> AYA Oncology Guideline. So proud to have you on the team. Congratulations to the panel and Dr Vadehra on this important and timely work! 👏 <a href="/TimothyJBrownMD/">Tim Brown, MD MSCE</a> <a href="/GIMedOnc/">Nicholas Hornstein</a> <a href="/UGrewalMD/">Udhayvir Grewal</a>
Udhayvir Grewal (@ugrewalmd) 's Twitter Profile Photo

🌍 Excited to be a part of the upcoming ENETS - NANETS International Webinar🇺🇸🇮🇱🇧🇬🇧🇪 Topic: Multidisciplinary management of pancreatic NETs (panNETs) 📅 Aug 28, 2025 | ⏰ 18:00–19:10 CEST / 12:00–13:10 EDT This case-based session will bring together experts from across

🌍 Excited to be a part of the upcoming <a href="/ENETS_ORG/">ENETS</a> - <a href="/NANETS1/">NANETS</a>  International Webinar🇺🇸🇮🇱🇧🇬🇧🇪

Topic: Multidisciplinary management of pancreatic NETs (panNETs)
📅 Aug 28, 2025 | ⏰ 18:00–19:10 CEST / 12:00–13:10 EDT
This case-based session will bring together experts from across